The unique platform which can be used to help develop better treatments for glioma is freely available at BioDynaMo.

Publishing today in the journal Methods, the team from the University of Cyprus, UCL and CERN describe how they have developed the three–dimensional model which brings together the macroscopic scale of tissue with the microscopic scale of individual cells. This allows the platform to realistically model cancer mechano-biology while maintaining the resolution power which makes it cost-effective.

Dr Roman Bauer from School of Computing at Newcastle University said: “Built on top of the latest computing technologies, the BioDynaMo platform enables users to perform simulations on an increased scale and complexity making it possible to tackle challenging scientific research questions.”

Although many specialised software tools exist, establishing this high-performance, general-purpose platform is a major step forward.

Jean de Montigny, PhD student from the Faculty of Medical Sciences at Newcastle University added: “The advantage for scientists and medics is that BioDynaMo can be used on standard laptops or desktop computers and provides a software platform which can be used to easily create, run and visualise 3D agent-based biological simulations.”

Glioma

Glioma is a broad category of brain and spinal cord tumours that originate from neural stem cells and glial cells that support neurons in the brain. Treatment for patients (who tend to be older adults) involves surgery to remove as much of the tumour as possible followed by chemotherapy and radiotherapy.

By modelling the growth of a glioma, clinicians can better understand how a tumour may develop and progress. Cancer researchers could use however such models in the future to improve the outcome of pertinent therapeutic procedures.

This paper develops a three-dimensional in silico hybrid model of cancer, which describes the multi-variate phenotypic behaviour of tumour and host cells. The model encompasses the role of cell migration and adhesion, the influence of the extracellular matrix, the effects of oxygen and nutrient availability, and the signalling triggered by chemical cues and growth factors.

Involving CERN, which contributed its deep knowledge in large-scale computing to this collaboration with Newcastle University, the project has been supported by Intel. Moreover, the University of Cyprus and UCL investigators contributed with their expertise in multiscale modelling.

Biodynamo is an international collaboration partially funded by the CERN Budget for Knowledge Transfer to Medical Applications.

Reference: An in silico hybrid continuum-/agent-based procedure to modelling cancer development: interrogating the interplay amongst glioma invasion, vascularity and necrosis. Jean de Montigny, Alexandros Iosif, Lukas Breitwieser, Marco Manca, Roman Bauer, Vasileios Vavourakis. https://doi.org/10.1016/j.ymeth.2020.01.006

Codes & data freely available from: https://biodynamo.org/ ; https://figshare.com/projects/In_silico_hybrid_FEM-ABM_model/67343

Heading 3 example

Text only.  For subheading use ‘Heading 3’

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec vel sapien lectus. Aliquam consectetur vitae tortor mattis sodales. Donec id quam id nulla tristique vestibulum. Ut vitae orci aliquam massa varius dapibus. Vivamus aliquet, lorem sit amet semper ultricies, ex tortor molestie felis, at ultrices tellus ligula vitae est. Sed gravida tortor sapien, in iaculis quam vestibulum vel. Duis et quam nec metus pharetra placerat. Donec in tellus pretium ex sagittis posuere. Nunc varius, libero at suscipit commodo, magna lacus facilisis velit, sed pellentesque magna eros vel dolor. Donec pretium neque ultrices, condimentum turpis non, porttitor neque. Suspendisse fermentum at lectus scelerisque mattis. Nam augue justo, iaculis quis euismod et, viverra in elit. Aliquam vitae justo malesuada, sodales urna et, aliquam nunc. Nulla placerat neque quis odio molestie, mattis bibendum turpis pellentesque.